Cargando…

Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer

BACKGROUND: Immunotherapy has emerged as a promising treatment strategy in malignant tumors. Inhibitors and neutralizing antibodies targeted PD-1 or PD-L1 show improved clinical outcomes in advanced non-small cell lung cancers (NSCLCs). Previous studies concluded that PD-1 was mainly expressed on ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Fanyi, Zhang, Chuanfen, Xia, Liang, Deng, Senyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841543/ https://www.ncbi.nlm.nih.gov/pubmed/35261880 http://dx.doi.org/10.21037/tcr-21-1644

Ejemplares similares

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer
por: Bai, Yuquan, et al.
Publicado: (2023)

Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer
por: Bai, Yuquan, et al.
Publicado: (2022)

Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway
por: Cheng, Jiahan, et al.
Publicado: (2022)

Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis
por: Peng, Zhiyu, et al.
Publicado: (2021)

Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma
por: Leng, Xuefeng, et al.
Publicado: (2021)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

Endogenous thrombopoietin promotes non‐small‐cell lung carcinoma cell proliferation and migration by regulating EGFR signalling
por: Zou, Zifang, et al.
Publicado: (2020)

Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival
por: Wang, Xinxin, et al.
Publicado: (2018)

Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
por: Wang, Zhao, et al.
Publicado: (2019)

ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
por: Zheng, Meng, et al.
Publicado: (2020)

Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
por: Zhang, Chuanfen, et al.
Publicado: (2022)

TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074
por: Lei, Jie, et al.
Publicado: (2014)

TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins
por: Zhan, Weihua, et al.
Publicado: (2015)

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Li, Jing, et al.
Publicado: (2020)

Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
por: Zhang, Pei-pei, et al.
Publicado: (2017)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
por: Zeng, Jing, et al.
Publicado: (2014)

PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2019)

A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
por: Bai, Yuquan, et al.
Publicado: (2022)

RBBP6 induces non-small cell lung cancer cell proliferation and high expression is associated with poor prognosis
por: Wang, Qiu-Shi, et al.
Publicado: (2020)

MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer
por: Lecuelle, Julie, et al.
Publicado: (2022)

The TWIST1-centered competing endogenous RNA network promotes proliferation, invasion, and migration of lung adenocarcinoma
por: Xia, Wenjie, et al.
Publicado: (2019)

PLAC1 is an independent predictor of poor survival, and promotes cell proliferation and invasion in cervical cancer
por: Chen, Rujun, et al.
Publicado: (2021)

LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival
por: Liang, Meng, et al.
Publicado: (2020)

High developmental pluripotency-associated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in non-small-cell lung cancer
por: Li, Longfei, et al.
Publicado: (2019)

MicroRNA-20a promotes non-small cell lung cancer proliferation by upregulating PD-L1 by targeting PTEN
por: Gong, Jiaomei, et al.
Publicado: (2022)

A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma
por: Bai, Yuquan, et al.
Publicado: (2020)

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

CD44 promotes cell proliferation in non-small cell lung cancer
por: Hu, Bo, et al.
Publicado: (2018)

CCDC106 promotes non-small cell lung cancer cell proliferation
por: Zhang, Xiupeng, et al.
Publicado: (2017)

FIGNL1 promotes non-small cell lung cancer cell proliferation
por: Li, Miao, et al.
Publicado: (2020)

ZMYM3 May Promote Cell Proliferation in Small Cell Lung Carcinoma
por: Kudo, Noritaka, et al.
Publicado: (2021)

Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy
por: Wang, Yixing, et al.
Publicado: (2021)

PD-L1 and c-MET expression and survival in patients with small cell lung cancer
por: Miao, Lulu, et al.
Publicado: (2017)

Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer
por: Feng, Shumei, et al.
Publicado: (2017)

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Cheng, Xu, et al.
Publicado: (2021)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer
por: Zhou, Cuiling, et al.
Publicado: (2017)

Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
por: Guo, Mengjie, et al.
Publicado: (2018)

CircMMP11 overexpression predicts the poor survival of non-small cell lung cancer and downregulates miR-143 through methylation to suppress cell proliferation
por: Chen, Juan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kvkkf5ncrhe14n28g8jocdo90u